MarketPulse

manufacturing issues

28 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bleichmar Fonti & Auld Llp

Eos Energy Faces Securities Lawsuit After 39% Stock Plunge on $970M Loss

Eos Energy investors sue over alleged fraud following massive $970M loss disclosure and 39% stock crash tied to manufacturing delays.
EOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

Atara Stock Crashes on FDA Rejection; Class Action Lawsuit Filed Over Alleged Disclosure Failures

Robbins LLP files class action against $ATRA over undisclosed manufacturing issues tied to FDA rejection of lead drug tabelecleucel, citing 57% stock plunge.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Atara Biotherapeutics Hit With Securities Lawsuit Over Tabelecleucel Drug Claims

Rosen Law Firm sues Atara Biotherapeutics for allegedly misrepresenting tabelecleucel drug's regulatory prospects and manufacturing capabilities to investors between May 2024 and January 2026. Lead plaintiff deadline set for May 22, 2026.
ATRAsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Atara Biotherapeutics Hit With Class Action Over Misleading FDA Study Claims

Class action lawsuit filed against $ATARAWITH alleging executives made false statements about manufacturing issues and ALLELE study deficiencies that could block FDA approval of tabelecleucel.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Energy Storage Stock EOSE Crashes 39% on Revenue Miss, Manufacturing Woes Spark Lawsuit

EOSE shares plunged 39% after missing FY 2025 revenue targets by 25% and revealing manufacturing delays. Securities lawsuit alleges management concealed production issues from investors.
EOSErevenue misssecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

EOSE Stock Crashes 39% as Eos Energy Faces Lawsuit Over Hidden Manufacturing Woes

$EOSE plummeted 39% after revealing 25% FY2025 revenue shortfall and production problems. Securities lawsuit alleges management concealed scaling issues from investors.
EOSErevenue misssecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bleichmar Fonti & Auld Llp

Eos Energy Faces Securities Probe Over Revenue Guidance Miss and Massive Loss

Eos Energy ($EOSE) faces federal securities investigation after 39% stock plunge following $970M loss and missed revenue targets reaffirmed in November 2025.
EOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bfa Law / Bleichmar Fonti & Auld Llp

Eos Energy Stock Plummets 39% as Securities Probe Targets Revenue Claims

BFA Law investigates $EOSE for securities fraud following 39% stock collapse tied to $970M loss, missed guidance, and manufacturing issues.
EOSEsecurities fraudclass action lawsuit